Bio

David joined Ampersand in 2010. Previously, David spent six years with Covington Associates, a specialty investment bank focused on middle-market M&A in the healthcare sector. Prior to Covington, he spent five years as a consultant for Boston Healthcare Associates. David's current and past board seats include Genezen, Arranta Bio, StageBio, Protogene, BioClinica, Brammer Bio, Cellero, and Vibalogics. David holds a B.Sc. from the University of Aberdeen, a Ph.D. in Immunology from the University of Sheffield and a M.B.A. from Babson College.